M

Matinas BioPharma Holdings
D

MTNB

2.49000
USD
0.03
(1.22%)
مغلق
حجم التداول
150
الربح لكل سهم
-2
العائد الربحي
-
P/E
-0
حجم السوق
2,439,005
أصول ذات صلة

العنوان: Matinas Biopharma Holdings Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.